Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Texas Children's Cancer Center Stories

2009-06-18 10:54:01

A grant from the Liddy Shriver Sarcoma Initiative will allow Dr. Pulivarthi Rao, associate professor of pediatrics at Baylor College of Medicine, and his team of researchers to explore the role of the gene CDC5L in the development of osteosarcoma, the most common bone cancer in children. Rao received the $50,000 one-year grant for his research proposal, "Molecular basis of genomic instability in osteosarcoma." "Osteosarcoma is often present with complex chromosomal rearrangements, deletions...

2009-05-18 15:52:30

Teenagers who are diagnosed with cancer face issues that younger patients do not, but fortunately programs have emerged at the Texas Children's Cancer Center (www.txccc.org) and others across the country geared just for them.The Texas Children's Cancer Center launched its adolescent program about four years ago, when staff realized that teens' emotional needs were not being met in the same way as the younger patients."It is critically important to their success not only with their cancer...

2008-10-08 12:00:37

Texas Children's Cancer Center today launched Passport for Care, an innovative Web-based application that provides childhood cancer survivors and their physicians with immediate access to a survivor's diagnosis and treatment history. Passport for Care provides detailed, individualized health care recommendations based on the most up-to-date national survivorship care guidelines. Passport for Care inventor and Texas Children's Cancer Center director Dr. David Poplack said the Web-based...

2008-09-08 12:00:41

Neogenix Oncology, Inc. (Neogenix) announced today that Philip M. Arlen, MD, was elected to the Board of Directors at its August 2008 meeting. The company also announced that Dr. Arlen had accepted the company's offer to become President and Chief Medical Officer, effective immediately. Dr. Philip M. Arlen is a Board Certified Medical Oncologist with extensive clinical experience in Medical Oncology as well as cancer research in the field of Tumor Immunology. Prior to joining Neogenix,...